Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greene, N. B.
Right arrow Articles by Baughman, R. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greene, N. B.
Right arrow Articles by Baughman, R. P.

Chest, Vol 91, 698-703, Copyright © 1987 by American College of Chest Physicians

ARTICLES

Patients with collagen vascular disease and dyspnea. The value of gallium scanning and bronchoalveolar lavage in predicting response to steroid therapy and clinical outcome

NB Greene, AM Solinger and RP Baughman

Patients with collagen vascular disease with or without pulmonary symptoms were studied to determine the value of gallium scan and bronchoalveolar lavage (BAL) in predicting clinical outcome and response to steroid therapy. Thirty-six subjects, 20 with progressive dyspnea, were studied. Gallium uptake was seen in the lung in 17 of the 20 progressively dyspneic patient's and none of the 16 nonprogressive patients (chi square = 22.5, p less than 0.001). The BAL fluid in the progressive patients had a higher percentage of neutrophils (13.4 percent +/- 2.88) and lymphocytes (16.1 percent +/- 2.75) than in the nonprogressive patients (neutrophils = 3.3 +/- 1.30 percent; lymphocytes = 5.6 +/- 1.57 percent, p less than 0.02 for both). Of the 19 progressive patients who were treated with steroids or cyclophosphamide, six had only increased neutrophils in their BAL fluid and all died. The remaining 13 treated progressive patients had increased lymphocytes or a normal BAL (two patients): six had improvement in their vital capacity, six have had stable function, and one died. We found gallium scan and BAL useful in assessing progressive pulmonary fibrosis in collagen vascular disease.


This article has been cited by other articles:


Home page
 J Intensive Care MedHome page
T. Yokoyama, T. Sakamoto, N. Shida, M. Kinoshita, Y. Kunou, R. Karukaya, M. Takamatsu, and H. Aizawa
Fatal Rapidly Progressive Interstitial Pneumonitis Associated With Amyopathic Dermatomyositis and CD8 T Lymphocytes
J Intensive Care Med, May 1, 2005; 20(3): 160 - 163.
[Abstract] [PDF]

Home page
 Eur Respir JHome page
C. Lamblin, C. Bergoin, T. Saelens, and B. Wallaert
Interstitial lung diseases in collagen vascular diseases
Eur. Respir. J., July 1, 2001; 18(32_suppl): 69S - 80s.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
N. Kodama, E. Yamaguchi, N. Hizawa, K. Furuya, J.-i. Kojima, M. Oguri, T. Takahashi, and Y. Kawakami
Expression of RANTES by Bronchoalveolar Lavage Cells in Nonsmoking Patients with Interstitial Lung Diseases
Am. J. Respir. Cell Mol. Biol., April 1, 1998; 18(4): 526 - 531.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American College of Chest Physicians.